JD Supra Law

AUGUST 12, 2024

Biosimilar Litigations include litigations relating to biosimilar/follow-on products of CDER-listed reference products. Litigations between biosimilar applicants/manufacturers and reference product sponsors as well as litigations between two biosimilar applicants/manufacturers are included. By: Venable LLP

Litigation 105

Litigation 105

JD Supra Law

AUGUST 19, 2024

Our Texas Patent Litigation Monthly Wrap-Up for July 2024 covers three decisions of interest from the Eastern District of Texas granting motions related to subject matter eligibility, stays pending inter partes review (IPR), and pleading standards for pre-suit willfulness. By: Fish & Richardson

Litigation 111

Litigation Patent 111

JD Supra Law

AUGUST 7, 2024

It has been a busy year for issues related to drug pricing, and with the election around the corner, litigation issues that have been developing over the last few years are likely to be a key focus for the second half of 2024.

Litigation 115

Litigation Business 115

JD Supra Law

AUGUST 13, 2024

Continuing our series on electric vehicle (EV) trade secret litigation, see here and here, a California judge has tentatively given Tesla the green light to proceed with a trial against rival Rivian in March of 2025.

Litigation 121

Litigation Technology 121

JD Supra Law

SEPTEMBER 26, 2024

In a sealed order that issued on September 24, 2024, the District Court for the Northern District of West Virginia denied a preliminary injunction against Amgen in the aflibercept BPCIA litigation. . By: Goodwin

Litigation 102

Litigation 102

JD Supra Law

SEPTEMBER 12, 2024

In patent litigation, expert witnesses play a crucial role in providing specialized knowledge to the court. In a recent case where Osseo Imaging LLC sued Planmeca USA Inc. for patent infringement, the Federal Circuit highlighted the importance of understanding expert witnesses' qualifications. By: Fenwick & West LLP

Litigation 109

Litigation Patent Patent Infringement 109

JD Supra Law

JANUARY 7, 2025

Trends to Watch in 2025 January 7, 2025 As we welcome 2025, Wilson Sonsini litigators shed light on the emerging trends and key issues they see shaping the legal landscape, from AI regulation to evolving trade secret laws and increasing scrutiny on corporate disclosures. By: Wilson Sonsini Goodrich & Rosati

Litigation 70

Litigation Law 70

JD Supra Law

NOVEMBER 27, 2024

While trade secret law may not get as much attention as copyright battles, it’s going to be a major player in the future of AI. With decades of legal development, it’s an essential area where companies will need to protect their innovations – or fend off others doing the same.

Litigation 114

Litigation Journalism Publishing Law 114

JD Supra Law

DECEMBER 13, 2024

This article is the second in our series on patent litigation strategies for cybersecurity companies. It expands on Tactic #1, Challenge the courts jurisdiction, from our earlier article, Five Tactics for Cybersecurity Companies to Defeat Patent Infringement Claims.. By: Fish & Richardson

Litigation 73

Litigation Patent Infringement Patent 73

Plagiarism Today

APRIL 5, 2022

When it comes to copyright, the photography space has been especially fraught with litigation and legal threats over the past decade plus. In short, the goal of the service is not to threaten users with litigation, but to bring them on as legitimate customers and provide education about best practices. Bottom Line.

Copyright Infringement 283

Copyright Infringement Copyright Licensing Litigation 283

SpicyIP

NOVEMBER 18, 2024

Image from here AI litigation seems to have reached India! OpenAI logo. Readers will be interested to know that ANI MEDIA PVT LTD V/s OPEN AI INC & ANR. has been listed before the IPD Bench of Justice Amit Bansal at Delhi High Court tomorrow (November 19, 2024 – Court Number 45, Item No.

Litigation 105

Litigation Copyright Publishing Reporting 105

JD Supra Law

AUGUST 14, 2024

Antibody-drug conjugates (ADCs) are typically composed of a monoclonal antibody attached to a cytotoxic drug via a chemical linker. The antibody is able to identify biomarkers on and attach to cancer cells, allowing targeted delivery of the cytotoxic drug without damaging surrounding, healthy cells.

Litigation 117

Litigation 117

JD Supra Law

AUGUST 19, 2024

Every practicing litigator knows the answer—“within 100 miles of where the person resides, is employed, or regularly transacts business in person.” What is the range of a federal district court’s power to compel a nonparty’s attendance at a hearing? FRCP 45(c)(1). But that is only half the answer.

Litigation 105

Litigation Business 105

SpicyIP

SEPTEMBER 4, 2024

Penning his 6 years long campaign to trace important public documents admittedly lost by the government, Prashant highlights the lack of transparency and shoddy record keeping by CDSCO and shares his exhausting experience with the resultant litigation before the DHC. Two or three adjournments and the case can easily be pushed by 10 months.

Litigation 97

Litigation Government Reporting Copying 97

IP Watchdog

OCTOBER 4, 2024

This week in Other Barks & Bites: Author files class action lawsuit against Meta for copyright infringement; Industry leaders urge Advisory Committee on Civil Rules to clarify third-party litigation; YouTube pulls popular music videos from platform amidst copyright dispute.

Copyright Infringement 105

Copyright Infringement Litigation Copyright Music 105

Intellectual Property Law Blog

FEBRUARY 10, 2023

As patent litigators are well-aware, the Western District of Texas and the District of Delaware, the two most popular venues for patent litigation, each issued orders regulating litigation in their districts in 2022. The orders require extensive disclosure of entities that are related to the parties and the litigations.

Patent 189

Patent Litigation Ownership 189

JD Supra Law

DECEMBER 23, 2024

Plaintiffs Dow Jones & Company, Inc., NYP Holdings, Inc., and corporate parent News Corporation have renewed their intellectual property (IP) complaint against artificial intelligence (AI)-powered answer engine Perplexity AI in the District Court for the Southern District of New York. By: ArentFox Schiff

Intellectual Property 119

Intellectual Property Litigation IP 119

JD Supra Law

JANUARY 2, 2025

On October 24, 2014, Amgen initiated the first litigation under the Biologics Price Competition and Innovation Act (BPCIA), asserting infringement of two patents. Over the last two calendar years, Amgen, Biogen, Genentech, and Regeneron have all filed BPCIA complaints (sometimes several) asserting 20 or more patents. By: Goodwin

Litigation 65

Litigation Patent 65

JD Supra Law

AUGUST 28, 2024

Restaurant, bar, club and tavern owners around the United States need to make sure they are properly licensing boxing fights for commercial usage before broadcasting the fight in their establishments.

Litigation 104

Litigation Intellectual Property Licensing 104

JD Supra Law

AUGUST 15, 2024

Universal Connectivity Tech. 1-23-cv-01506 (W.D. 34, Report and Recommendation of Magistrate Judge Susan Hightower to Judge Pitman - A magistrate judge recommended denying defendant Dell Technologies, Inc.’s s motion to dismiss in the Western District of Texas when Dell argued that pre-suit knowledge is a prerequisite for indirect infringement.

Litigation 106

Litigation Reporting Patent Technology 106

JD Supra Law

NOVEMBER 20, 2024

Dow Jones & Company, Inc. and NYP Holdings, Inc. Perplexity AI, Inc. Plaintiffs Dow Jones and Company, Inc. and NYP Holdings, Inc., publishers of The Wall Street Journal and New York Post, (collectively, Plaintiffs), have filed a lawsuit in the Southern District of New York against defendant Perplexity AI, Inc.

Litigation 104

Litigation Journalism Copying Publishing 104

Plagiarism Today

NOVEMBER 17, 2022

However, it’s an important case to keep in mind, especially litigation over music seems to be on the rise. In 2022, we seem to be in a time when litigation over music is ever-present. In the end, the case is more of a footnote in both the film’s history and the history of copyright. Why It’s Worth Remembering.

Copyright 338

Copyright Music Copyright Infringement Plagiarism 338

JD Supra Law

AUGUST 20, 2024

LEGISLATION, REGULATIONS & STANDARDS - EPA Takes Emergency Action to Stop Use of Dacthal - For the first time in nearly 40 years, the U.S.

Litigation 105

Litigation Registration 105

Plagiarism Today

OCTOBER 4, 2022

This case clearly illustrates how, with copyright, two different cases with nearly identical facts can have wildly different outcomes depending on the court and the litigators involved. Songwriting and Litigation. There’s not much doubt that there is more litigation around songwriting.

Copyright 234

Copyright Music Litigation Plagiarism 234

IP Watchdog

OCTOBER 15, 2024

There are two distinct procedures available to parties for resolving patent infringement matters in China: an administrative procedure before the IP office and a civil procedure before the courts.

Patent Infringement 104

Patent Infringement Intellectual Property Patent Litigation 104

IP Watchdog

OCTOBER 15, 2024

The highly publicized ruling came after almost a decade of litigation between the parties over VIP’s “Bad Spaniels” parody dog toy designed to mimic a bottle of Jack Daniel’s. The litigation that has unfolded in the past year foretells the downstream implications of the Supreme Court ruling, particularly for trademark dilution law.

Trademark 124

Trademark Litigation IP Designs 124

Plagiarism Today

AUGUST 3, 2023

Bell is the author of Winning Isn't Normal, but he's made a name as a regular litigant. Author Keith F. Now, he's coming to the CCB. The post ‘Winning Isn’t Normal’ Author Files First Cases with the CCB appeared first on Plagiarism Today.

Plagiarism 174

Plagiarism Litigation Copyright Law Law 174

JD Supra Law

AUGUST 13, 2024

Pegfilgrastim Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple litigations/IPRs are counted more than once. Within each litigation a claim is counted only once.

Litigation 111

Litigation Patent 111

JD Supra Law

AUGUST 12, 2024

Rituximab Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple litigations/IPRs are counted more than once. Within each litigation a claim is counted only once.

Litigation 110

Litigation Patent 110

JD Supra Law

AUGUST 13, 2024

Etanercept Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple litigations/IPRs are counted more than once. Within each litigation a claim is counted only once.

Litigation 109

Litigation Patent 109

JD Supra Law

AUGUST 12, 2024

Trastuzumab Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple litigations/IPRs are counted more than once. Within each litigation a claim is counted only once.

Litigation 107

Litigation Patent 107

Erik K Pelton

JANUARY 6, 2022

Patent and Trademark Office; Assisting with discovery and motions in litigation matters; and. Intern duties will include: Assisting associates with all aspects of trademark clearance, registration, and counsel; Drafting responses Office Actions at the U.S. Immersion in the activities and work of a boutique law firm.

Intellectual Property 231

Intellectual Property Intellectual Property Law Trademark Registration 231

JD Supra Law

AUGUST 12, 2024

Adalimumab Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple litigations/IPRs are counted more than once. Within each litigation a claim is counted only once.

Litigation 108

Litigation Patent 108

Intellectual Property Law Blog

APRIL 12, 2023

The Guide covers the following topics and includes links to the relevant materials: The USCO Artificial Intelligence Initiative Copyright Registration Guidance: Works Containing Material Generated by Artificial Intelligence Recent USCO Actions on Applications with Generative AI Materials Past Activity by the USCO on AI Some Recent Litigations Involving (..)

Copyright 240

Copyright Registration Music Copyright Law 240

Plagiarism Today

JUNE 28, 2022

We’ve seen mass litigation against news agencies , paparazzi repeateldy sue celebrities over Instagram post and lots of demand letters filed on behalf of photographers. The cost of litigation meant that, in many cases, demand letters had no teeth. This has led us down some difficult paths.

Copyright 222

Copyright Litigation Plagiarism Copyright Infringement 222

JD Supra Law

AUGUST 23, 2024

Welcome to the latest issue of Blockbuster Biologics Review, which covers the status and developments of post-grant challenges and patent litigations implicating blockbuster biologics and legislative proposals related to biosimilars in Q3 2024. By: Morgan Lewis

Litigation 115

Litigation Patent 115

JD Supra Law

AUGUST 12, 2024

Insulin Glargine Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent challenged in multiple litigations/IPRs are counted more than once. Within each litigation a claim is counted only once.

Litigation 101

Litigation Patent 101